• Solid Biosciences Inc (SLDB)

    $8.96 | $0.46 (5.13%)

  • Dividend Yield

    0.00%

  • SSR Rating

    28

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Solid Biosciences, lead product candidate the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

  • Last Price:
    $8.96
  • Previous Close:
    $8.50
  • Change:
    $0.46 (5.41%)
  • Open:
    $8.73
  • Volume:
    1,055,379
  • Average Volume (100 Day):
    560,080
  • Market Capitalization:
    $317.5 M
  • Day's Range:
    $8.50 - $9.12
  • Dividend Yield:
    0.00%
  • 52-week Range:
    $55 - $5.97
  • P-E:
    0.00
  • EPS:
    $-1.61
  • Earnings Date:
    4/4/19
  • Ex Dividend Date:
    N/A
  • Sector:
    Healthcare
  • Industry:
    Drug Manufacturers - Specialty & Generic
  • Analyst Average Recommendation:
    ■Hold